NF2-type neurofibromatosis-related vestibular nerve sheath tumor immortalized cell line as well as construction method and application thereof
By transfecting SV40 and HPV-16E6/E7 genes into primary cells of NF2 neurofibromatosis-related vestibular schwannoma, the NF2-VS-Llab-1 cell line was constructed, solving the lack of effective NF2 nerves in the prior art. The problem of immortalized cell lines related to fibromatosis provides a good homogeneous research model, supporting in-depth research and exploration of therapeutic targets for NF2 diseases.
Patent Information
- Application Number
- CN202411115891.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-14
- Publication Date
- 2024-11-26
AI Technical Summary
The lack of effective immortalized cell lines of vestibular schwannoma associated with NF2 neurofibromatosis in the prior art is difficult to meet the needs of disease research and therapeutic target exploration, especially cell lines directly derived from patients who are aging after passage. It is impossible to continuously provide a good homogeneous research model.
By transfecting exogenous immortalized genes SV40 and HPV-16E6/E7 into primary cells of NF2 neurofibromatosis-related vestibular schwannoma, positive clones were introduced and screened for positive clones, a sustainable proliferation of NF2 type NF2 type was constructed by transfecting exogenous immortalized genes SV40 and HPV-16E6/E7 into primary cells of NF2 neurofibromatosis-related vestibular schwannoma, the positive clones were introduced and screened for positive clones were screened. Neurofibular schwannoma immortalized cell line NF2-VS-Llab-1, associated with neurofibromatosis.
A continuous passage of NF2 neurofibromatosis-related vestibular schwannoma immortalized cell line was successfully constructed, providing a good homogeneous experimental model, meeting the needs of NF2 disease research, and providing a potential therapeutic target for exploring potential therapeutic targets. Effective tools.
Smart Images

Figure CN119020294A_ABST
Abstract
Description
Technical Field
[0001] The embodiments of the present invention relate to the field of cell engineering technology, and specifically to an immortalized cell line of vestibular schwannoma associated with NF2 neurofibromatosis and a construction method and application thereof. Background Art
[0002] NF2-related schwannomatosis (NF2) is an autosomal dominant genetic disease. Mutations in the Nf2 gene on chromosome 22q12 cause inactivation of the tumor suppressor protein merlin, resulting in multiple lesions in multiple systems. The clinical manifestations of NF2 include bilateral vestibular schwannomas (incidence 90%-95%), multiple meningiomas (incidence 45%-58%), cataracts (incidence 60%-81%), and skin tumors (incidence 59%-68%). Other relatively rare clinical manifestations include spinal ependymomas and peripheral neuropathy. Since the above lesions continue to progress in the course of NF2, it is difficult to achieve a radical cure through a single surgical treatment. Therefore, it is urgent to explore systemic treatment options to reduce the tumor burden of patients.
[0003] To further explore the treatment of NF2, accurate and efficient NF2 preclinical models are needed as research tools to reveal the pathogenesis, disease progression, tumor heterogeneity and therapeutic targets. Preclinical models mainly include immortalized cell lines, transplanted tumor animal models and gene-edited animal models, which can verify the efficacy, toxicity and adverse reactions of treatment plans from multiple perspectives. Cell lines are commonly used, relatively inexpensive and easy to operate models. Most primary cells directly extracted from patients age and die after several passages, which cannot meet research needs. Immortalized cell lines established by introducing exogenous immortalization genes such as SV40T (SV40 large T antigen) and SV40 (human telomerase reverse transcriptase) into primary cells through gene transfection and other technologies have the ability to proliferate indefinitely and can provide a research model with good homogeneity.
[0004] Currently, the only cell line reported to be directly derived from NF2 patients is the NF2 vestibular schwannoma cell line HEI193. More immortalized cell lines are urgently needed to fully reflect the disease phenotype of NF2 and explore potential therapeutic targets for NF2. Summary of the invention
[0005] To this end, the embodiments of the present invention provide an immortalized cell line of vestibular schwannoma related to NF2 neurofibromatosis and a construction method and application thereof. The cell line can proliferate and be passaged continuously with no difference between cells, thus providing an experimental basis for research in the field related to NF2 neurofibromatosis.
[0006] In order to achieve the above purpose, the embodiment of the present invention provides the following technical solutions:
[0007] According to the first aspect of an embodiment of the present invention, the present invention provides an immortalized cell line NF2-VS-Llab-1 of vestibular schwannoma related to NF2 neurofibromatosis, which is deposited in the General Microbiology Center of China Microorganism Culture Collection Administration, with a deposit number of CGMCC No.45803 and a deposit time of January 10, 2024.
[0008] According to the second aspect of an embodiment of the present invention, the present invention provides a method for constructing an immortalized cell line of NF2 neurofibromatosis-related vestibular schwannoma as described above, transfecting exogenous immortalization genes SV40 and HPV-16E6 / E7 into primary cells of NF2 neurofibromatosis-related vestibular schwannoma, screening positive clones and subculturing to obtain an immortalized cell line of NF2 neurofibromatosis-related vestibular schwannoma.
[0009] Furthermore, the method includes: inoculating NF2 neurofibromatosis-related vestibular schwannoma primary cells in a six-well plate, using a lentiviral vector to introduce exogenous immortalization genes SV40 and HPV-16E6 / E7 into the cells, culturing in an incubator at 37°C, 5% CO2 for 12 hours, and then replacing with fresh culture medium for continued culturing; using 1 μg / mL of puromycin for one week to screen successfully infected cells, observing the cells after they have grown full, and subculturing them. If the cells continue to proliferate and subculture for more than 20 generations, the immortalized cell line is considered to be successfully established.
[0010] Furthermore, the culture medium is: DMEM complete culture medium containing 10% fetal bovine serum.
[0011] Furthermore, the method for preparing primary cells of NF2 neurofibromatosis-related vestibular schwannoma comprises the following steps:
[0012] 1) Add digestive enzymes to fresh NF2-related vestibular schwannoma specimens and place in an incubator at 37°C and 5% CO2 for 2-4 hours;
[0013] 2) Filter to remove undigested debris, collect the cell filtrate, centrifuge at 1000 rpm for 5 minutes, and discard the supernatant;
[0014] 3) Add red blood cell lysis buffer to the precipitate and let it stand for 2 minutes, then add 10 mL PBS to resuspend, centrifuge at 1000 rpm for 5 minutes, and discard the supernatant;
[0015] 4) Add 10 mL of PBS to the precipitate to resuspend it, centrifuge at 1000 rpm for 5 minutes, and discard the supernatant;
[0016] 5) Add DMEM complete medium containing 10% fetal bovine serum to the precipitate to resuspend it, transfer it to a culture dish, and culture it in an incubator at 37° C. and 5% CO 2 ;
[0017] 6) The medium was changed every 48-72 hours, the cells were observed under a microscope, and vestibular schwannoma cell clones were selected for expansion culture to obtain NF2 neurofibromatosis-related vestibular schwannoma primary cells.
[0018] Furthermore, the digestive enzyme includes papain, trypsin or collagenase.
[0019] Furthermore, the filtration uses a cell filter with a particle size of 70 μm or 40 μm.
[0020] According to a third aspect of an embodiment of the present invention, the present invention provides a use of the immortalized cell line of NF2 neurofibromatosis-related vestibular schwannoma as described above, wherein the use is selected from any one of the following:
[0021] a. Prepare NF2 neurofibromatosis-related vestibular schwannoma cell or animal models;
[0022] b. preparing a medicament for treating NF2 neurofibromatosis-related vestibular schwannoma;
[0023] c. Screening for therapeutic targets for vestibular schwannomas associated with NF2 neurofibromatosis.
[0024] The embodiments of the present invention have the following advantages:
[0025] The present invention introduces exogenous immortalization genes SV40 and HPV-16E6 / E7 into NF2-related vestibular schwannoma cells through lentiviral vectors, successfully constructs an immortalized NF2-related vestibular schwannoma cell line that can be continuously proliferated and propagated, and confirms the effectiveness of the construction method. The present invention provides a preclinical research model with good homogeneity and simple operation for research in the field of NF2-related research. BRIEF DESCRIPTION OF THE DRAWINGS
[0026] In order to more clearly illustrate the implementation methods of the present invention or the technical solutions in the prior art, the following briefly introduces the drawings required for the implementation methods or the description of the prior art. Obviously, the drawings in the following description are only exemplary, and for ordinary technicians in this field, other implementation drawings can be derived from the provided drawings without creative work.
[0027] Figure 1 The observation results of the P1 generation of the primary cell line of vestibular schwannoma associated with NF2 neurofibromatosis provided by the present invention;
[0028] Figure 2 The immunofluorescence results of specific antigens of the schwannoma cells of the primary cell line P1 of NF2 neurofibromatosis-related vestibular schwannoma provided by the present invention;
[0029] Figure 3 The comparison results of the relative expression of the SV40 gene provided by the present invention;
[0030] Figure 4 The comparison results of the relative expression of HPV-16E6 / E7 genes provided by the present invention;
[0031] Figure 5 The present invention provides the observation results of the immortalized cell line P35 of NF2 neurofibromatosis-related vestibular schwannoma. DETAILED DESCRIPTION
[0032] The following is a description of the implementation of the present invention by specific embodiments. People familiar with the art can easily understand other advantages and effects of the present invention from the contents disclosed in this specification. Obviously, the described embodiments are part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.
[0033] Example 1 Isolation and culture of primary cells of NF2 neurofibromatosis-related vestibular schwannoma
[0034] 1. Isolation and culture of primary cells of NF2 neurofibromatosis-related vestibular schwannoma
[0035] 1) Take fresh NF2 neurofibromatosis-related vestibular schwannoma specimens removed by surgery, keep them sterile, and transport them to the laboratory ultra-clean cell workbench at 4°C.
[0036] 2) Rinse the specimen with PBS, remove blood stains and electrocoagulation burn sites, place in a 100 mm culture dish, and cut into pieces of approximately 1 mm*1 mm.
[0037] 3) Add 10 mL of 20 U / mL papain to 0.5 g of the sample and place in an incubator at 37°C and 5% CO2 for digestion for 4 hours.
[0038] 4) Filter with a 70 μm cell strainer to remove undigested debris, collect the cell filtrate, centrifuge at 1000 rpm for 5 minutes, and discard the supernatant.
[0039] 5) Add red blood cell lysis buffer to the precipitate, let it stand for 2 minutes, then add 10 mL of PBS to resuspend, centrifuge at 1000 rpm for 5 minutes, and discard the supernatant.
[0040] 6) Add 10 mL of PBS to the precipitate and resuspend it. Centrifuge at 1000 rpm for 5 minutes and discard the supernatant.
[0041] 7) Add DMEM complete medium containing 10% fetal bovine serum to the precipitate to resuspend it, transfer it to a culture dish, and culture it in an incubator at 37° C. and 5% CO 2 .
[0042] 8) The medium was changed every 72 hours, the cells were observed under a microscope, and the vestibular schwannoma cell clones were selected for expansion culture to obtain the primary cells of NF2 neurofibromatosis-related vestibular schwannoma P1 ( Figure 1 ).
[0043] 2. Identification of primary cells of NF2-related vestibular schwannoma
[0044] The specific antigen SOX10 of schwannoma cells was selected for immunofluorescence staining. The red fluorescence indicated the expression of SOX10 in the cytoplasm, and the blue fluorescence was DAPI indicating the cell nucleus. The cells were identified as schwannoma cells ( Figure 2 ).
[0045] Example 2 Establishment and culture of immortalized cell line of NF2 neurofibromatosis-related vestibular schwannoma
[0046] 1. Establishment and culture of immortalized cell lines of NF2 neurofibromatosis-related vestibular schwannoma
[0047] 1) Prepare DNA / Lentifectin virus packaging mixture: Add 140μg pLenti HPV-16E6 / E7 Vector / pLenti SV40 Vector expression plasmid and 168μg lentiviral transfection auxiliary plasmid 2nd Generation Packaging Mix to 10ml serum-free medium, mix well, and incubate at room temperature for 5min. Add 900μl Lentifectin transfection reagent to another 10ml serum-free medium, mix well, and incubate at room temperature for 5min. Mix the above plasmid mixed solution and Lentifectin mixed solution, incubate at room temperature for 20min, and then add 40ml serum-free medium to obtain a DNA / Lentifectin mixture. Remove the old medium from the 293T cell culture dish, add the DNA / Lentifectin mixture, and culture in an incubator at 37°C and 5% CO2. After 24 hours, fresh DMEM medium containing 10% fetal bovine serum was replaced. After 48 hours, the medium was collected, filtered through a 0.45 μm PVDF membrane, and centrifuged at 10,000 g for 4 hours to collect and obtain HPV-16E6 / E7 lentiviral particles and SV40 lentiviral particles.
[0048] 2) The NF2 neurofibromatosis-related vestibular schwannoma primary cells of passage P1 were inoculated into a six-well plate. According to the optimal MOI value determined in the preliminary experiment of 10-20, 15 μl of the HPV-16E6 / E7 expressing lentiviral particles and SV40 lentiviral particles obtained in step 1 were added to the six-well plate, gently shaken to mix, and cultured in an incubator at 37° C., 5% CO2 for 12 h, and then replaced with fresh DMEM complete medium containing 10% fetal bovine serum for continued culture.
[0049] 3) Use 1 μg / mL of puromycin for one week to select the successfully infected cells, and then subculture the cells after they have grown to full size. If the cells continue to proliferate and subculture for more than 20 generations, the immortalized cell line is considered to have been successfully established.
[0050] The cell line that has proliferated and passaged for more than 20 generations was preserved and named NF2-VS-Llab-1, with the preservation number CGMCC No.45803 and the preservation date of January 10, 2024.
[0051] 2. Detection of immortalized cell lines of NF2-related vestibular schwannoma
[0052] (1) SV40 and HPV-16E6 / E7 were detected in the primary cell line P3 of NF2-related vestibular schwannoma and the immortalized cell line P30 of NF2-related vestibular schwannoma by fluorescence quantitative PCR technology.
[0053] RNA was extracted from the primary cell line P3 and the immortalized cell line P30, respectively, and reverse transcribed into cDNA, which was used as a template for DNA amplification, and then Real-time PCR was used for fluorescence quantitative analysis.
[0054] The results showed that SV40 and HPV-16E6 / E7 were correctly expressed in immortalized cell lines of NF2-related vestibular schwannoma ( Figure 3-4 ).
[0055] (2) The NF2-related vestibular schwannoma primary cell line and the NF2-related vestibular schwannoma immortalized cell line were subjected to genotype short tandem repeat sequence (STR) detection. The results are shown in Table 1 below.
[0056] Table 1
[0057]
[0058]
[0059] The results showed that the STR of the primary cell line of NF2 neurofibromatosis-related vestibular schwannoma and the immortalized cell line of NF2 neurofibromatosis-related vestibular schwannoma were completely matched, confirming that the two cell lines were from the same tissue and there was no cross-contamination.
[0060] (3) In vitro cell culture and cell morphology observation
[0061] The immortalized cell line of NF2 neurofibromatosis-related vestibular schwannoma cultured in vitro was subcultured to the 35th generation. The cells proliferated and were subcultured approximately every 5 days, showing good cell activity. Under the bright field microscope, the cells were spindle-shaped and grew in a single layer ( Figure 5 ).
[0062] Although the present invention has been described in detail above by general description and specific embodiments, it is obvious to those skilled in the art that some modifications or improvements can be made to the present invention. Therefore, these modifications or improvements made without departing from the spirit of the present invention all belong to the scope of protection claimed by the present invention.
Claims
1. An immortalized cell line NF2-VS-Llab-1 for vestibular schwannoma associated with NF2 neurofibromatosis, characterized in that: It is deposited in the General Microbiology Center of China Culture Collection Administration, with the deposit number CGMCC No.45803 and the deposit date being January 10, 2024.
2. A method for constructing an immortalized cell line of NF2 neurofibromatosis-related vestibular schwannoma according to claim 1, characterized in that: The exogenous immortalization genes SV40 and HPV-16E6 / E7 were transfected into primary NF2-related vestibular schwannoma cells, and positive clones were screened and subcultured to obtain NF2-related vestibular schwannoma immortalized cell lines.
3. The construction method according to claim 2, characterized in that The method comprises: Primary NF2-related vestibular schwannoma cells were seeded in six-well plates, and exogenous immortalization genes SV40 and HPV-16E6 / E7 were introduced into the cells using lentiviral vectors. The cells were cultured in a 37°C, 5% CO2 incubator for 12 hours, and then fresh medium was replaced and continued to culture. Successfully infected cells were screened using 1 μg / mL puromycin for one week. After the cells were observed to be confluent, they were passaged. If the cells continued to proliferate and be passaged for more than 20 generations, the immortalized cell line was considered to be successfully established.
4. The construction method according to claim 3, characterized in that The culture medium is: DMEM complete culture medium containing 10% fetal bovine serum.
5. The construction method according to claim 3, characterized in that The method for preparing primary cells of NF2 neurofibromatosis-related vestibular schwannoma comprises the following steps: 1) Add digestive enzymes to fresh NF2-related vestibular schwannoma specimens and place in a 37°C, 5% CO2 incubator for 2-4 hours; 2) Filter to remove undigested debris, collect the cell filtrate, centrifuge at 1000 rpm for 5 minutes, and discard the supernatant; 3) Add red blood cell lysis buffer to the pellet, let it stand for 2 minutes, then resuspend it in 10 mL of PBS, centrifuge at 1000 rpm for 5 minutes, and discard the supernatant; 4) Add 10 mL of PBS to the pellet and resuspend. Centrifuge at 1000 rpm for 5 minutes and discard the supernatant. 5) Add DMEM complete medium containing 10% fetal bovine serum to the pellet to resuspend it, transfer it to a culture dish, and culture it in an incubator at 37°C and 5% CO2; 6) The medium was changed every 48-72 hours, the cells were observed under a microscope, and vestibular schwannoma cell clones were selected for expansion culture to obtain primary NF2 neurofibromatosis-related vestibular schwannoma cells.
6. The construction method according to claim 5, characterized in that: The digestive enzymes include papain, trypsin or collagenase.
7. The construction method according to claim 5, characterized in that: The filtration uses a cell strainer with a particle size of 70 μm or 40 μm.
8. The use of the immortalized cell line of NF2 neurofibromatosis-related vestibular schwannoma according to claim 1, characterized in that: The use is selected from any one of the following: a. Prepare NF2 neurofibromatosis-related vestibular schwannoma cell or animal models; b. Preparation of a medicament for treating NF2 neurofibromatosis-associated vestibular schwannoma; c. Screening for therapeutic targets for vestibular schwannomas associated with neurofibromatosis NF2.
